loading...
loading...
loading...

Drug Controller Approves Commercial Launch Of Low Cost Covid Test Feluda

https://ift.tt/eA8V8J
https://www.ndtv.com
The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...

from NDTV News - Topstories https://ift.tt/2FMnI1j
via IFTTT

Post a Comment

[blogger]

Author Name

Contact Form

Name

Email *

Message *

Powered by Blogger.